If you were trying to artificially devalue a company by adding entry EBITDA adjustments that will increase the purchase price but wouldn't be credited in the exit EBITDA, what would some examples of those be?
What would be some examples of items that would achieve the opposite effect?
| +255 | Return Rates For Interns Are Falling? | 104 | 6h |
| +136 | UBS Americas IB: The Kids’ Table of Wall Street | 18 | 12h |
| +111 | I am a drunk MD AMA | 39 | 22h |
| +72 | Article: Why UBS's Asian M&A bankers are thriving and UBS's American M&A bankers are not | 9 | 2m |
| +64 | VP Lifestyle at Top BB Coverage Groups | 40 | 1d |
| +60 | UBS Offer Day | 23 | 12h |
| +57 | An Outsider’s View of RX Banking Out of College | 6 | 4d |
| +50 | SharePoint makes IB hours HELL | 15 | 4d |
| +40 | WF Return offers | 27 | 7h |
| +36 | I hate Wells Fargo | 6 | 8h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Eius qui itaque qui saepe molestiae eum porro. Dolorum totam eum quia optio. Quo natus dignissimos numquam praesentium non commodi numquam. Aut optio dolorum sed totam consequatur nihil modi quod. Cum dicta est amet magni deleniti eligendi.
Rerum ex expedita quam assumenda sed. Aut error incidunt laudantium ex.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...